IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX

主要组织相容性复合体的免疫生物学

基本信息

项目摘要

The long-term objective of the proposed research is to learn what the avian major histocompatibility complex (MHC) can tell us about the evolution of the MHC gene complex and the means by which this MHC confers disease resistance. The proposed study provides an opportunity to contrast the strucutre of a non-mammalian MHC, the B system of the chicken, with the MHCs of mouse and man. It is already known that one B system subregion, the B-G subregion, encodes antigens which are differrent from known gene products associated with the MHC of mammals. While these antigens are highly polymorphic and their genes tightly-linked with those of the class I and class II antigens encoded within the B system, they are clearly different from all ohter MHC-encoded molecules. partial sequence data derived from a B-B cDNa clone isolated in this labe indicates that the B-G antigens contain a domain more closely similar to immunoglobulin and T-cell receptor variable region domains (recognition domains) than to Ig-constant region domains such as those found within class I and class II antigens. Another important aspect of the B system is the particularly strong association found between the presence of the B-F/B-L subregion genes and resistance to Marek's disease, a herpesvirus-induced lymphoma. Hence, the B system provides a model in which to study the relationship between the MHC and viral disease when suitable reagents become available. The specific aims are 1) to complete a structural analysis of the B-G21 antigens, produce a restriction enzyme map of the B-G gubregion and link B-G to the B-F and B-L subregions; 2) to undertake molecular cloning of B-F21 and B-L21 genes and complete a similar molecular genetic analysis of these B subregions which encode the avian class I and class II-like gene counterparts, and 3) we would like to begin to apply the information learned in the present study to the investigation of the process of infection and tumorigenesis caused by Marek's disease virus.
拟议研究的长期目标是了解 鸟类主要组织相容性复合体(MHC)可以告诉我们 MHC基因复合体的进化以及这种进化的方式, MHC赋予抗病性。 这项研究提供了一个 有机会对比非哺乳动物MHC的结构, 鸡的B系统,小鼠和人的MHC。 已知一个B系统子区域,B-G子区域, 编码不同于已知基因产物的抗原 与哺乳动物的MHC有关。 虽然这些抗原 高度多态性,其基因与 在B系统内编码的I类和II类抗原,它们是 明显不同于所有其他MHC编码的分子。 部分 从本实验室分离的B-B cDNa克隆中获得的序列数据, 表明B-G抗原含有一个结构域, 类似于免疫球蛋白和T细胞受体可变区 结构域(识别结构域)比Ig-恒定区结构域 例如在I类和II类抗原中发现的那些。 B系统的另一个重要方面是 发现B-F/B-L亚区的存在与 马立克氏病是一种疱疹病毒引起的疾病, 淋巴瘤 因此,B系统提供了一个研究模型 MHC与病毒性疾病之间的关系 试剂变得可用。 具体目标是:1)完成对 B-G21抗原,产生B-G gubregion并将B-G连接到B-F和B-L子区域; 2)连接到 进行B-F21和B-L21基因的分子克隆, 对这些B亚区进行类似的分子遗传学分析, 编码禽类I类和II类基因对应物,和 3)我们希望开始应用在 本研究旨在探讨感染过程, 马立克氏病病毒引起的肿瘤。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Antigens similar to major histocompatibility complex B-G are expressed in the intestinal epithelium in the chicken.
与主要组织相容性复合物 B-G 相似的抗原在鸡的肠上皮中表达。
  • DOI:
    10.1007/bf01787328
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Miller,MM;Goto,R;Young,S;Liu,J;Hardy,J
  • 通讯作者:
    Hardy,J
Biochemical confirmation of recombination within the B-G subregion of the chicken major histocompatibility complex.
鸡主要组织相容性复合体 B-G 亚区内重组的生化确认。
  • DOI:
    10.1007/bf00351086
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Miller,MM;Goto,R;Briles,WE
  • 通讯作者:
    Briles,WE
Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells.
通过病毒特异性细胞毒性 T 细胞对转染马立克氏病病毒基因的网状内皮增生病毒转化细胞系进行同基因裂解。
Restriction fragment polymorphisms at the chicken anion transporter (band 3) locus.
鸡阴离子转运蛋白(带 3)位点的限制性片段多态性。
  • DOI:
    10.1111/j.1365-2052.1992.tb00146.x
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Miller,MM;Goto,R;Miyada,CG;Abplanalp,H
  • 通讯作者:
    Abplanalp,H
Characterization of Mhc genes in a multigenerational family of ring-necked pheasants.
环颈雉多代家系 Mhc 基因的特征。
  • DOI:
    10.1007/bf00176673
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Jarvi,SI;Goto,RM;Briles,WE;Miller,MM
  • 通讯作者:
    Miller,MM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARCIA M MILLER其他文献

MARCIA M MILLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARCIA M MILLER', 18)}}的其他基金

Equipment for Visualization of Fragile Subcellular Detail by Electron Microscopy
通过电子显微镜观察脆弱亚细胞细节的设备
  • 批准号:
    7595603
  • 财政年份:
    2009
  • 资助金额:
    $ 15.21万
  • 项目类别:
MHC Loci in the Control of Marek's Lymphoma
MHC 位点控制马立克氏淋巴瘤
  • 批准号:
    6909121
  • 财政年份:
    2004
  • 资助金额:
    $ 15.21万
  • 项目类别:
MHC Loci in the Control of Marek's Lymphoma
MHC 位点控制马立克氏淋巴瘤
  • 批准号:
    6821450
  • 财政年份:
    2004
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132030
  • 财政年份:
    1989
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132026
  • 财政年份:
    1985
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132023
  • 财政年份:
    1985
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132021
  • 财政年份:
    1985
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132027
  • 财政年份:
    1985
  • 资助金额:
    $ 15.21万
  • 项目类别:
IMMUNOBIOLOGY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX
主要组织相容性复合体的免疫生物学
  • 批准号:
    3132028
  • 财政年份:
    1985
  • 资助金额:
    $ 15.21万
  • 项目类别:

相似海外基金

The roles of polymorphism in Meq on the pathogenicity of Marek's disease virus and their application for the vaccine development
Meq多态性对马立克氏病病毒致病性的作用及其在疫苗研发中的应用
  • 批准号:
    23H02375
  • 财政年份:
    2023
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on mechanisms of enhanced virulence of oncogenic Marek's disease virus
致癌马立克氏病病毒增强毒力机制研究
  • 批准号:
    23KJ0067
  • 财政年份:
    2023
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
A novel platform for producing cell-free third generation Marek's disease virus vaccine
生产无细胞第三代马立克氏病病毒疫苗的新平台
  • 批准号:
    BB/T020954/2
  • 财政年份:
    2023
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Research Grant
Effects of co-infections on Marek's disease in poultry and development of novel recombinant Marek's disease virus vector vaccines
混合感染对家禽马立克氏病的影响及新型重组马立克氏病病毒载体疫苗的研制
  • 批准号:
    BB/X017575/1
  • 财政年份:
    2023
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Research Grant
A novel platform for producing cell-free third generation Marek's disease virus vaccine
生产无细胞第三代马立克氏病病毒疫苗的新平台
  • 批准号:
    BB/T020954/1
  • 财政年份:
    2022
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Research Grant
Marek's disease avian herpesvirus - Learning from differences
马立克氏病禽疱疹病毒 - 从差异中学习
  • 批准号:
    RGPIN-2022-03680
  • 财政年份:
    2022
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Discovery Grants Program - Individual
US-UK Collab: The consequences of transmissible vaccines on disease ecology and pathogen evolution: Marek's disease virus as a case study
美英合作:传染性疫苗对疾病生态学和病原体进化的影响:以马立克氏病病毒为例
  • 批准号:
    BB/V017748/1
  • 财政年份:
    2021
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Research Grant
Mechanisms of cell to cell spread of Marek's Disease Virus
马立克氏病病毒细胞间传播的机制
  • 批准号:
    2590886
  • 财政年份:
    2021
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Studentship
US-UK Collab: The consequences of transmissible vaccines on disease ecology and pathogen evolution: Marek's disease virus as a case study
美英合作:传染性疫苗对疾病生态学和病原体进化的影响:以马立克氏病病毒为例
  • 批准号:
    10393692
  • 财政年份:
    2020
  • 资助金额:
    $ 15.21万
  • 项目类别:
Kinesin-mediated transport of Marek's disease virus
驱动蛋白介导的马立克氏病病毒运输
  • 批准号:
    2391881
  • 财政年份:
    2020
  • 资助金额:
    $ 15.21万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了